Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11413323 Ophthalmic composition for treatment of dry eye disease

Patent 11413323 was granted and assigned to Novaliq on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128010 Semifluorinated compounds and their compositions
0
Edits on 14 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12059449 Ophthalmic composition for treatment of dry eye disease
0
Edits on 1 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 12 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12005033 Compositions comprising mixtures of semifluorinated alkanes
0
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alice Meides0
Chiara Silvana Leo0
Sonja Krösser0
Thomas Schlüter0
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 17 Aug, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 17 Aug, 2022
Edits made to:
Infobox (+21 properties)
Article (+263 characters)
‌

 US Patent 11413323 Ophthalmic composition for treatment of dry eye disease

Article

The invention provides ophthalmic compositions comprising about 0.1 % (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. The invention further provides kits comprising such compositions for the same use.

Infobox
Is a
Patent
Patent
Patent Applicant
‌
Novaliq
Current Assignee
‌
Novaliq
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11413323
Date of Patent
August 16, 2022
Patent Application Number
17228309
Date Filed
April 12, 2021
Patent Citations
‌
US Patent 10045996 Pharmaceutical composition for treatment of increased intraocular pressure
‌
US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes
Patent Primary Examiner
‌
Jeffrey T. Palenik
CPC Code
‌
A61J 1/00
‌
A61J 1/1468
‌
A61J 1/067
‌
A61K 47/06
‌
A61K 47/10
‌
A61K 9/08
‌
A61K 9/0048
‌
A61P 27/02
‌
A61K 31/00
‌
A61K 38/13

Find more entities like US Patent 11413323 Ophthalmic composition for treatment of dry eye disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.